Kim Beckham, an insurance agent in Texas Victoria, saw that friends suffered so much pain in blankets.
His doctor and several pharmacies said they could not administer vaccines because they were not recommended at that time. So in 2016 he celebrated his 60th birthday in the local CV.
Beckham recalled: He said, “I was very relieved after receiving an injection from Zostavax.” Since then, he has received cubic vaccines for pneumonia, more effective cubic vaccines for pneumonia: pneumonia, synchronous respiratory virus (VRS), annual dosage for the flu and all people recommended for Covid-19.
Some elderly people are very pleased to be vaccinated.
Robin Wolaner (71), a retired editor of California’s Sosal Lito, knows her about being suspected of being taken for a recommended vaccine and sending medical research. “I graduated a little bit,” he admitted.
The 66 -year -old Deana Hendrickson, who cares for three small grandchildren in Los Angeles, demanded an additional capacity of the triple virus castle (SPR), but she was vaccinated for measles, paper and girls, but she prepared for a decrease in immunity to measles.
In recent months for the elderly who are more confident in vaccine than the young group, they have been very positive.
Recent studies have found an important advantage that new vaccines, improved versions and others can provide unpredictable benefits.
The new study arrives at tense political moments. Secretary of State Robert F. Kennedy Jr. has long loved a specific vaccine, and he qualified for anxiety and the government officials who regulated them were corrupt and compromised.
On June 9, Kennedy replaced the science advisory panel at the Centers for Disease Control and Prevention Center (CDC) and replaced it as a skeptical part of vaccination. But until now, Kennedy has not tried to limit the antivirus of major Americans.
Evidence that the vaccine is beneficial is still overwhelming.
Phrase “The vaccine is no longer for children” He has become one of the favorite features of William Schaffner, an epidemic expert at the Vanderbilt Medical Center University.
“The population over 65 years of age or older, which is influenced by the respiratory virus and other the worst of the respiratory viruses and others, is now benefiting from the vaccine to prevent most of these serious diseases.”
Let’s get 140,000 to 710,000 people to the hospital every year. adult10%of the elderly admitted are fatal.
For about 15 years, the CDC has approved some improved flu vaccines for people aged 65 or older. Effective than standard formulations, these vaccines contain higher levels of antigens including a supplement that produces protection of viruses or generates stronger immune responses. They are also recombinant vaccines developed in different ways, with higher levels of antigens.
In the meta -analysis published in the American Geriatrics Society Journal, “all improved vaccines were higher than the standard capacity to prevent hospitalization,” said REBECCA MORGAN, a health research method scholar of Case Western Reserve.
Standard flu vaccine, compared to improved vaccines They reduced the risk of flu humanity For the elderly between 11% and 18%. CDC recommendation Adults aged 65 or older Many people receive improved vaccines as they have already done.
Better news: The vaccine that prevents the synthetic respiratory virus of people aged 60 or older is getting good results.
VRS is the most common cause of the baby’s hospitalization and is an important risk for the elderly. “The season after Temporad,” said Schaffner said that the season of respiratory diseases competing with influenza. “
In the 2023-24 season, the US pharmaceutical and food management (FDA), which first approved the VRS vaccine in 2023, provided the first opportunity to observe it for the first time. Recent study Published in Jama Network Open Magazine.
When analyzing the electronic medical records of almost 800,000 patients, the researchers found 75%of the vaccines for acute infections. In other words, diseases such as patients require a promise with a health provider.
The vaccine had 75 %efficacy for 75 %in the emergency room prevention, 75 %in hospitalization, and 75 %for people aged 60 to 74.
Terebuh has a slightly lower level of protection of the vaccine, but patients with immunosuppressions will benefit from vaccination.
Regarding side effects, this study has a very low risk of Guillain-Barré syndrome, an abnormal state, which causes muscle weakness and generally occurs after infection. “You shouldn’t block people,” he stressed.
CDC now recommends vaccinations for VRs of people aged 75 or older (for example, due to heart disease), and if there is a high risk of serious illness, it is recommended for 60-74 years.
When data is provided from the 2024-25 season, researchers hope to determine whether the vaccine remains in a single capacity or whether immunity requires immunity every time.
According to the KFF survey conducted in April, people aged 65 or older express their greatest trust in vaccine security than any other adult group. More than 80% of them have a “many” or “something” confidence in measles vaccines, rubella, pneumonia and flu.
The covid vaccine had a lower support among adults, but more than two -thirds of the elderly expressed their trust in safety.
Even skeptics can be excited about the possible benefits of blanket vaccines. This spring, researchers at Stanford University reported that vaccinations for alcohol have decreased in seven years. 20%dementia riskDiscovery on the news headline.
Prejudice often undermines observation studies that compare vaccinated groups. PASCAL GELDSETZER, an epidemiologist of the initiative article for Stanford’s brain resilience, said, “The most healthy people and those with the most motivated for health are people who are vaccinated.
“It’s less likely to cause the cause and the result or anyway,” he added.
So Stanford’s team used the “Natural Experiment” when the first vaccine for Wales’ Zostavax, Herpes Zóter, was introduced. Health authorities said that those who turned 80 years before September 1, 2013, were not eligible to be vaccinated, but they worked a little younger.
In nearly 300,000 samples, which matched the date of the date, almost half of the eligible group received the vaccine, but in reality anyone in the elderly group did.
“As in any essay, this comparison group should be similar in all aspects. The significant decrease in dementia diagnosis in the eligible group for vaccines has a much greater protection for women and constitutes” more powerful and convincing evidence. “
The team also observed a decrease in dementia rate after introducing a vaccine for herpes zóters. In Australia And other countries. “We continue to observe this in the data set,” GeldSetzer concluded.
SHINGRIX, a more powerful vaccine, began in 2017 and replaced Zostavax in the United States, which replaced researchers at Oxford University. Stronger.
When comparing almost 104,000 major Americans who received the first dose of the new vaccine (two complete vaccinations), the shingrix group was delayed in the shingrix group.
It has not yet explained how the vaccine for herpes zóters can reduce dementia. Scientists suggested that the virus itself can contribute to dementia, so suppressing it can protect the brain. Perhaps the vaccine usually revives the immune system or affects inflammation.
Paul Harrison, a major author of Psychiatrist Izai, Oxford University, said, “No one knows anyone.” But “I’m sure there’s something really here,” he said.
There is a shingrix recommended for adults aged 50 or older. 90% efficacy Herpes prevention zóters and ongoing neuronal pain that can be created. But in 2021 Only 41%of adults aged 60 or older He received some vaccines for herpes Joe Sther.
The relationship with dementia will require more research, and GELDSETZER is trying to raise funds from Park Ae -ju chair for clinical trials.
Schaffner said, “If you need another reason to vaccinate, Schaffner said.
